首页> Journal of Crohn's & colitis> Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Luisa,Guidi

第一单位： OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

作者： Luisa,Guidi ^[1] ; Daniela,Pugliese ^[1] ; Tommaso,Panici Tonucci ^[1] ; Alexandra,Berrino ^[2] ; Barbara,Tolusso ^[3] ; Michele,Basile ^[2] ; Laura,Cantoro ^[4] ; Paola,Balestrieri ^[5] ; Fortunata,Civitelli ^[6] ; Lorenzo,Bertani ^[7] ; Manuela,Marzo ^[1] ; Carla,Felice ^[1] ; Elisa,Gremese ^[3] ; Francesco,Costa ^[7] ; Franca,Viola ^[6] ; Michele,Cicala ^[5] ; Anna,Kohn ^[4] ; Antonio,Gasbarrini ^[8] ; Gian Lodovico,Rapaccini ^[1] ; Matteo,Ruggeri ^[2] ; Alessandro,Armuzzi ^[1]

作者单位： OU Internal Medicine and Gastroenterology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. ^[1] Postgraduate School of Health Economics and Management [Altems], Catholic University of the Sacred Heart, Rome, Italy. ^[2] OU Rheumatology Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. ^[3] IBD Unit, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy. ^[4] OU Gastroenterology, Campus Biomedico University, Rome, Italy. ^[5] OU Pediatric Gastroenterology, La Sapienza University, Rome, Italy. ^[6] OU University Gastroenterology, AOU Pisana, Pisa, Italy. ^[7] OU Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. ^[8]

关键词 Biologics Crohn’s disease health economics ulcerative colitis